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Introduction 
 Equine Piroplasmosis (EP) is a tick-borne 
disease also referred to as babesiosis or theileriosis.  
This disease can affect horses, donkeys, mules, and 
zebras. Theileria equi and Babesia caballi are the 
causative parasitic agents of this disease which is 
spread by tick bites or through mechanical 
transmission by improperly disinfected 
instruments.1 Considered endemic (native to an 
area) in many tropical regions including Africa, 
Europe, the Middle East, Asia, Central and South 
America, EP is a foreign animal disease in the 
United States, and is not endemic here. Approxi-
mately 14 species of ticks can be vectors for the 
organisms that cause this disease. Potential tick 
vectors for T. equi and B. caballi exist in the U.S.   
 
Transmission 
 Equine Piroplasmosis occurs naturally when 
ticks ingest blood from an infected horse and then 
bite an uninfected horse, thereby spreading the 
parasite through blood contact. The disease 
replicates in the tick, making spread of the disease 
to multiple horses likely. Currently, there is only 
one known area in the U.S., located in southeast 
Texas, where tick transmission of EP agents has 
been shown to occur.1 Equine Piroplasmosis is also 
spread iatrogenically by humans using skin 
penetrating instruments without properly sanitizing 
these instruments or disposing of them between 
horses. These instruments include needles, syringes, 
dental equipment, tattoo equipment, and surgical 
tools.2 The majority of recent outbreaks in the 
United States have been attributed to iatrogenic 
transmission rather than the natural transmission  
via ticks.   
Clinical Disease and Diagnosis 
 The blood borne parasites T. equi and B. 
caballi attach to the red blood cells and cause their 
destruction. After a horse is infected it can take 
from 7 to 30 days to show signs of the disease.   
Cases of EP may be unapparent, mild or acute. Mild 
cases can appear as loss of appetite or weakness, 
while more acute severe signs include fever, 
anemia, weight loss, jaundice, fluid accumulation in 
the abdomen, decreased performance, edema in the 
lower limbs, and even death. Because EP is not 
endemic in the U.S., our horses are naïve and highly 
susceptible to the acute forms of the disease.1 Mild 
forms of the disease may go completely unnoticed 
by horse owners. After the initial stages of the 
disease, EP may become chronic. Horses can carry 
the parasites for long periods of time with no 
clinical signs. This leads to a horse becoming a 
carrier that can spread the disease to other horses by 
mechanical or natural routes.   
 Because the clinical signs of EP are similar 
to other diseases, it can be challenging to diagnose 
without appropriate testing. The accepted method to 
diagnose EP is to test the serum or blood for 
antibodies to T. equi and B. caballi. Testing can 
take several days and may need to be sent to a 
national laboratory for confirmation testing. Due to 
the foreign animal disease designation in the United 
States, positive samples require notification of state 
and federal regulatory officials. Additionally, 
international notice to the World Organization for 
Animal Health (OIE) is conducted. The OIE is the 
international organizations that establishes 
standards for the safe international trade of 
animals.2 
 Today the United States enjoys the status of 
being free of EP from a travel and export 
perspective. The importance of protecting this 
designation cannot be understated when considering 
the negative economic impact the U.S. would incur 
if travel and trade were restricted as a result of 
allowing this disease to become endemic in the 
United States. 
 
Prevention and Treatment 
 Current options for treating a horse testing 
positive for EP are limited. These options include 
life-long quarantine overseen by federal regulatory 
officials, euthanasia, and treatment. Treatment of 
EP is only permissible if the horse is enrolled in a 
USDA supervised research program. The goal of 
treatment is to completely clear the horse of 
infection. Although identification of a treatment 
protocol that can provide permanent clearance of 
EP from an infected animal would be ideal, it is not 
an outcome that can be guaranteed. The positive 
antibody status of the horse remains for many 
months and, in some cases, up to 2 years after 
successful treatment and the horse must remain 
quarantined during this time. 
 Prevention is vital to stop the spread of EP.  
In areas where the host tick is known to live, efforts 
to control ticks and keep them off horses have 
proven important. These ticks are one host ticks. 
They spend their life cycle on the same host as 
much as possible. In the United States, recent EP 
outbreaks have occurred in areas where the host tick 
is not known to live. These outbreaks have been 
isolated and caused by reusing needles and syringes 
between horses. The American Association of 
Equine Practitioners gives these guidelines:1 
 
 
 
 
 
ALWAYS: 
• Use a new sterile needle and syringe for 
injections, whether into a vein or muscle or 
beneath the skin. 
• Carefully clean and disinfect equine dental, 
tattoo and surgical equipment between horses. 
• Have any horse that will serve as a blood donor 
tested for EP. 
• Contact your veterinarian if your horse is sick 
and has signs of fever, reduced feed intake or 
lethargy. 
• Check with your State Animal Health Official 
if you need more specifics about EP.     
 
Conclusion 
 Equine Piroplasmosis can be a devastating 
disease to horse owners and the horse industry.  
Understanding this disease and how it is spread will 
help us keep horses safe. With current outbreaks 
being limited to the race horse industry, the Utah 
Racing Commission has implemented a new 
commission order effective September 9, 2016, 
stating “no horse shall enter a sanctioned race track 
in Utah without first providing a negative Theileria 
equi cELISA test administered within the last 
twelve (12) months.” With these measures 
implemented in Utah and surrounding states, 
hopefully the current and potential threat EP poses 
to horses can be prevented. 
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